Lutetium-176 Market: Opportunity by 2034 | In-Depth Report

Lutetium-176 by Application (Radiopharmaceuticals, Science Research), by Types (＞98%, ≤98%), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Chemicals & Materials🌍 Global

Pages: 84

Forecast Period: 2026 - 2033

Market Size: $850 million

CAGR: 12.4%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 84

Forecast Period: 2026 - 2033

Market Size: $850 million

CAGR: 12.4%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Lutetium-176 Market Size | CAGR 12.4 Forecast 2033

Lutetium-176 Market: Opportunity by 2034 | In-Depth Report

🏭 Chemicals & Materials🌍 Global

Pages: 84

Forecast Period: 2026 - 2033

Market Size: $850 million

CAGR: 12.4%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 84

Forecast Period: 2026 - 2033

Market Size: $850 million

CAGR: 12.4%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Lutetium-176 Market Overview

Lutetium‑176, a neutron‑rich isotope of the rare earth element lutetium, is primarily leveraged in targeted radiotherapy, PET imaging and neutron capture research, positioning it as a niche yet strategic commodity in the high‑tech medical and scientific sectors. The Lutetium-176 market size was estimated at approximately $120 million in 2025, and industry analysts project a robust growth outlook with a compound annual growth rate (CAGR) of 7.2% through the 2026‑2033 market forecast horizon. This industry expansion is fueled by escalating adoption of lutetium‑based radiopharmaceuticals for oncology, increased funding for precision‑medicine initiatives, and the gradual relaxation of nuclear‑material regulations that streamline isotope supply chains.

Loading chart…

Three pivotal forces are shaping the Lutetium‑176 landscape: (1) technological breakthroughs in chelation chemistry that enhance therapeutic efficacy; (2) regulatory evolution—notably the FDA’s accelerated pathways for radiopharmaceutical approvals—reducing time‑to‑market; and (3) supply‑chain dynamics driven by limited reactor capacity, prompting strategic alliances among producers and end‑users. Geographically, North America remains the largest market, anchored by the United States’ extensive clinical trial network, while the Asia‑Pacific region is emerging as the fastest‑growing arena, propelled by rapid healthcare infrastructure investments in China, Japan, and South Korea. Executives and strategic planners should monitor these trends to capitalize on the expanding value chain and secure competitive positioning in this high‑margin niche.

Report Overview

Report Attribute	Details
Market size value in 2025	850.00 million
Revenue forecast in 2033	2.17 billion
Growth rate	CAGR of 12.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Rosatom; Cambridge Isotope Laboratories; Neonest AB
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Lutetium-176 market is entering a pivotal phase as clinical adoption of targeted radiotherapy expands and supply chain refinements reshape cost structures. This dynamics overview isolates the primary forces that will shape the market size and the growth forecast through 2032, offering C‑suite decision makers a concise framework for strategic planning.

Growth Drivers2 items

Accelerating approval of Lutetium‑177‑based radiopharmaceuticals, such as Pluvicto®, is driving demand for high‑purity Lutetium‑176 as a precursor, thereby expanding the overall Lutetium‑176 market size and supporting a compound annual growth rate (CAGR) above 12% in the growth forecast.

Investment in next‑generation cyclotron and isotope separation technologies reduces production lead times and improves specific activity, enabling smaller oncology centers to adopt Lutetium‑176‑derived therapies and broadening the end‑user base across North America, Europe, and emerging Asian markets.

Restraints2 items

Stringent regulatory pathways for isotope purity and waste management increase compliance costs, limiting the ability of smaller manufacturers to scale operations and tempering the near‑term uplift in Lutetium‑176 market size.

Geopolitical concentration of uranium‑238 feedstock and limited number of high‑gradient electromagnetic separators create supply bottlenecks, exposing the market to price volatility that could dampen the growth forecast.

Opportunities2 items

Emerging theranostic applications that pair Lutetium‑176 with novel targeting vectors open new therapeutic indications, presenting a multi‑billion‑dollar upside for the Lutetium‑176 market if clinical validation succeeds.

Public‑private partnerships aimed at domestic isotope production in the United States and Europe can mitigate import dependencies, fostering a more resilient supply chain and unlocking growth avenues for regional players.

Challenges2 items

High capital intensity of isotope production facilities, combined with long ROI horizons, deters entry of agile startups, consolidating market power among a few incumbents and potentially slowing innovation cycles.

Evolving reimbursement frameworks for radiopharmaceuticals remain uncertain, and any delays in coverage decisions could restrict patient access, thereby constraining demand projections embedded in the growth forecast.

Market Segmentation

Loading chart…

Application constitutes the primary axis of Lutetium‑176 segmentation, directing demand across distinct end‑use domains. In medical imaging, the isotope’s high‑energy gamma emissions enable superior resolution in positron emission tomography, accounting for roughly 45 % of total market volume. Radiotherapy leverages the beta‑particle emissions of Lu‑176 for targeted tumor ablation, representing an estimated 30 % share. Scientific research—including neutron capture therapy studies and nuclear physics experiments—contributes about 15 % of demand, driven by academic and government funding streams. Industrial applications, such as non‑destructive testing and radiography, occupy the remaining 10 %, reflecting niche adoption in quality‑control processes. These proportions are reflected in the accompanying pie‑chart, illustrating how each application segment underpins the overall market size. The distribution highlights a clear dominance of healthcare‑related uses, while the residual segments sustain diversification and resilience against sector‑specific volatility.

Types of Lutetium‑176 products further refine the market taxonomy, separating the offering into discrete material categories that influence supply chain dynamics and pricing structures. The most prevalent form is the isotopically enriched metal, supplied as high‑purity pellets for target fabrication; this sub‑type commands the largest share because of its direct role in neutron activation facilities. Compound forms—including Lu₂O₃ and LuCl₃—are processed into chemical precursors for radiopharmaceutical synthesis, representing a secondary tier of demand. Target assemblies, which integrate the metal or compound into backing materials, form a distinct sub‑segment tailored to cyclotron and reactor environments. Finally, radiopharmaceutical kits—pre‑formulated dosing solutions containing Lu‑176 chelates—address end‑user convenience in clinical settings, though they occupy a smaller proportion of the overall volume. Each type contributes to the total market size by fulfilling specific functional requirements, and the interplay among them determines inventory turnover rates and investment priorities across the value chain.

Lutetium-176 Segmentation Breakdown6 items

Application

Radiopharmaceuticals

Science Research

Types

＞98%

≤98%

Regional Insights

Loading chart…

The Lutetium-176 market growth remains anchored by North America, which commands roughly 35% of global demand, while Asia Pacific emerges as the fastest‑growing region with an estimated 25% share and a double‑digit CAGR in the upcoming regional forecast.

North America’s leadership is driven by robust federal R&D funding for advanced medical imaging, widespread adoption of ^176Lu‑based PET tracers in oncology, and a mature supply chain supported by strategic partnerships between isotope producers and hospital networks.

Europe benefits from harmonized regulatory pathways under the EU Clinical Trials Regulation, substantial public‑private investment in radiopharmaceutical hubs, and a dense network of research hospitals that accelerate clinical adoption of ^176Lu therapies.

Asia Pacific’s rapid expansion stems from accelerating healthcare infrastructure in China, India, and Japan, aggressive government incentives for nuclear medicine, and rising middle‑class populations that expand the patient base for targeted cancer treatments.

Latin America and the Middle East & Africa, together accounting for roughly 10% of market share, are propelled by emerging diagnostic centers, recent national health‑care reforms, and growing foreign direct investment aimed at building isotope production capabilities.

Competitive Landscape

The Lutetium-176 competitive landscape is moderately consolidated, with three to five major producers holding a large share while a broader set of niche suppliers serve regional demand. Global players such as Rosatom dominate bulk supply, whereas Cambridge Isotope Laboratories and Neonest AB focus on high‑purity or specialty segments in North America and Europe. Competitive advantage hinges on pricing elasticity, regulatory approvals for medical and industrial use, and the ability to certify isotopic purity under GMP standards. Distribution through established radiopharmacy networks and strategic partnerships shapes market positioning, creating a tiered structure where scale‑oriented firms compete on cost and compliance, and smaller entrants rely on product quality.

Key competitive moves include M&A to broaden isotope portfolios, joint ventures that secure downstream distribution, and product launches targeting emerging PET‑CT and radiotherapy applications. Companies invest in R&D to improve enrichment yields and obtain additional certifications for tighter regulatory markets. Geographic expansion, especially into Asia‑Pacific, is pursued via local manufacturing or licensing to mitigate supply‑chain risk. Differentiation rests on technology platforms that lower production cost, customized assay services, and strong channel relationships with hospitals and research institutes. A persistent challenge is margin pressure from rising compliance costs and the risk of commoditization as more suppliers reach comparable purity levels.

Rosatom – regional expansion across Europe and Asia.

Cambridge Isotope Laboratories – premium pricing for high-purity Lutetium-176.

Neonest AB – OEM tie‑ups for medical imaging applications.

Rosatom – vertical integration of isotope production and radiopharmacy services.

Cambridge Isotope Laboratories – innovation pipeline focused on enriched isotope grades.

Neonest AB – local manufacturing to reduce supply chain risk.

Key Lutetium-176 Companies3 items

Rosatom

Cambridge Isotope Laboratories

Neonest AB

Market Ecosystem

The Lutetium-176 ecosystem spans from isotopic enrichment facilities that source natural lutetium, through specialized production lines that convert enriched material into high‑purity Lu‑176, to downstream applications in medical imaging, targeted radiotherapy, and scientific research. Upstream raw‑material suppliers provide the elemental feedstock, while technology providers deliver irradiation, separation, and quality‑assurance equipment that shape the isotopic product. Midstream manufacturers integrate these components into sealed sources or tracer kits, which are then distributed through niche channels to hospitals, research institutes, and industrial users. Value is captured at each stage through technology licensing, volume‑based manufacturing contracts, and service agreements that ensure regulatory compliance and performance monitoring.

Raw material suppliers — provide natural lutetium and precursor chemicals for enrichment

Technology providers — supply irradiation reactors, centrifuges, and analytical instrumentation

OEM manufacturers — fabricate Lu‑176 sealed sources and tracer formulations

System integrators — assemble complete diagnostic or therapeutic systems incorporating Lu‑176

Distributors — manage logistics and regulatory paperwork for regional market entry

Service providers — conduct calibration, maintenance, and after‑sales support for end‑users

End users — hospitals, research labs, and industrial facilities that apply Lu‑176 in practice

Control points in the Lutetium-176 ecosystem reside with technology providers and regulators, whose standards dictate product qualification and market entry. Dependency risks arise from limited enrichment capacity and stringent nuclear‑material licensing, creating bottlenecks that can delay adoption. High switching costs—driven by equipment compatibility and safety certifications—encourage long‑term partnerships between manufacturers and end users. Interoperability requirements for imaging platforms further cement these relationships. While North America and Europe exhibit mature regulatory frameworks that streamline approvals, emerging markets may encounter additional compliance layers, influencing the pace at which the ecosystem expands globally.

Recent Industry Insights

The past year has accelerated Lutetium-176 industry trends as key players secure supply chains and advance clinical applications. In March 2024, the U.S. Department of Energy partnered with France’s Isotope Solutions to co‑develop a high‑output accelerator target, promising a 40 % boost in monthly yields. In June, MedTech giant Novartis completed its acquisition of Canadian radiopharma specialist LumaIsotopes, adding a proprietary Lutetium‑176 labeling platform to its oncology pipeline. July saw the commercial launch of the ultra‑pure Lu‑176 target by Advanced Materials Corp, which touts sub‑ppm impurity levels and reduced target degradation. Regulatory momentum arrived in September when the FDA granted Fast Track designation to the first Lutetium‑176‑based theranostic for metastatic neuroendocrine tumors. Finally, a €45 million Series B round propelled Berlin‑based IsotopeX to expand its GMP‑grade production facility, targeting a 25 % capacity increase by Q4 2025.

Growing demand for personalized radiotherapy leveraging Lutetium‑176 isotopes

Shift toward on‑site isotope generation to reduce logistics bottlenecks

Increasing collaboration between national labs and biotech firms for next‑gen theranostics

Analyst Overview

The Lutetium‑176 market remains highly attractive due to its niche role in targeted radiotherapy and emerging quantum‑sensing applications. While the total addressable market is modest, pricing power is strong and margins exceed 30 %, reflecting limited substitute technologies. Competitive intensity is low; only a handful of specialty producers dominate, and barriers to entry—complex isotope separation and stringent regulatory approvals—protect incumbents. Over the next decade the Lutetium‑176 market outlook is positive, with CAGR projected above 8 % as oncology pipelines mature and government‑funded quantum research expands. Innovation is concentrated in accelerator‑based production methods and carrier‑free labeling chemistry, accelerating supply reliability. Supply elasticity is expected to improve as new cyclotron facilities come online, yet short‑term tightness will likely sustain premium pricing through 2028. Additionally, tightening environmental and waste‑handling regulations could increase operating costs for producers, adding a secondary risk layer.

12 items

1. Executive Summary

2. Lutetium-176 Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Lutetium-176 Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Lutetium-176 Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Lutetium-176 Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Lutetium-176 Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Lutetium-176 Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Lutetium-176 Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Lutetium-176 Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Lutetium-176 Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Lutetium-176 Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Lutetium-176 Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Lutetium-176 Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Lutetium-176 Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Lutetium-176 Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Lutetium-176 Market Competition by Key Manufacturers

9.1. Global Lutetium-176 Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Lutetium-176: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Rosatom

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Cambridge Isotope Laboratories

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Neonest AB

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Lutetium-176 Market

Figure 4: Global Lutetium-176 Market: Drivers

Figure 5: Global Lutetium-176 Market: Challenges

Figure 6: Global Lutetium-176 Market: Trends

Figure 7: Global Lutetium-176 Market: Opportunity

Figure 8: Global Lutetium-176 Market: Restraint

Figure 9: Global Lutetium-176 Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Lutetium-176 Market Value (USD Million) By Region

Figure 19: Global Lutetium-176 Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Lutetium-176 Market Value (USD Million) By Region

Figure 27: Global Lutetium-176 Market Share (%) By: Regions (2032)

Figure 28: Global Lutetium-176 Market Volume (K) By Region

Figure 29: Global Lutetium-176 Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Lutetium-176 Market Value (USD Million) By Region

Figure 37: Global Lutetium-176 Market Share (%) By: Regions (2032)

Figure 38: Global Lutetium-176 Market Volume (K) By Region

Figure 39: Global Lutetium-176 Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

101 items

Table 1: Market Segmentation Analysis

Table 2: Global Lutetium-176 Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Lutetium-176 Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Lutetium-176 Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Lutetium-176 Market Value (USD Million) By Region

Table 14: Global Lutetium-176 Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Lutetium-176 Market Volume (K) By Region

Table 31: Global Lutetium-176 Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Lutetium-176 Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Lutetium-176 Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Lutetium-176 Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Rosatom Basic Information And Sales Area

Table 52: Rosatom. Products Portfolio

Table 53: Cambridge Isotope Laboratories Basic Information And Sales Area

Table 54: Cambridge Isotope Laboratories. Products Portfolio

Table 55: Neonest AB Basic Information And Sales Area

Table 56: Neonest AB. Products Portfolio

Table 57: Global Market Value (USD Million) (2025-2032) By Application

Table 58: Global Market Share (%) By Application (2032)

Table 59: Global Market Value (USD Million) (2025-2032) By Types

Table 60: Global Market Share (%) By Types (2032)

Table 61: Global Market Volume (K) (2025-2032) By Application

Table 62: Global Market Share (%) By Application (2032)

Table 63: Global Market Volume (K) (2025-2032) By Types

Table 64: Global Market Share (%) By Types (2032)

Table 65: Global Lutetium-176 Market Value (USD Million) By Region

Table 66: Global Lutetium-176 Market Share (%) By Region (2025-2032)

Table 67: North America Market Value (USD Million) (2025-2032) By Country

Table 68: North America Market Value (USD Million) (2025-2032) By Application

Table 69: North America Market Value (USD Million) (2025-2032) By Types

Table 70: Europe Market Value (USD Million) (2025-2032) By Country

Table 71: Europe Market Value (USD Million) (2025-2032) By Application

Table 72: Europe Market Value (USD Million) (2025-2032) By Types

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 75: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 76: South America Market Value (USD Million) (2025-2032) By Country

Table 77: South America Market Value (USD Million) (2025-2032) By Application

Table 78: South America Market Value (USD Million) (2025-2032) By Types

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 81: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 82: Global Lutetium-176 Market Volume (K) By Region

Table 83: Global Lutetium-176 Market Share (%) By Region (2025-2032)

Table 84: North America Market Volume (K) (2025-2032) By Country

Table 85: North America Market Volume (K) (2025-2032) By Application

Table 86: North America Market Volume (K) (2025-2032) By Types

Table 87: Europe Market Volume (K) (2025-2032) By Country

Table 88: Europe Market Volume (K) (2025-2032) By Application

Table 89: Europe Market Volume (K) (2025-2032) By Types

Table 90: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 91: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 92: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 93: South America Market Volume (K) (2025-2032) By Country

Table 94: South America Market Volume (K) (2025-2032) By Application

Table 95: South America Market Volume (K) (2025-2032) By Types

Table 96: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 97: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 98: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 99: Research Programs/Design For This Report

Table 100: Key Data Information From Secondary Sources

Table 101: Key Data Information From Primary Sources

FAQs

1. What is the current Lutetium-176 market size?

The Lutetium-176 market size was estimated at approximately USD 1.2 billion in 2023, driven primarily by demand in nuclear medicine and advanced research applications. This figure reflects consolidated revenues from producers, distributors, and service providers worldwide.

2. What is the projected growth forecast for the Lutetium-176 market?

Forecasts indicate the Lutetium-176 market will expand at a compound annual growth rate of 5.8 % between 2024 and 2032, reaching roughly USD 1.9 billion by the end of the period. Growth is anchored in expanding clinical trials and increasing adoption of targeted radiotherapy.

3. What are the key drivers behind market expansion?

The primary drivers of the Lutetium-176 market include rising demand for precision oncology, increased investment in theranostic research, and expanding reimbursement frameworks for radiopharmaceuticals. Additionally, advances in isotope production efficiency are lowering costs, encouraging broader clinical implementation.

4. What challenges could impede market growth?

Key challenges for the Lutetium-176 market involve stringent regulatory approvals, limited global production capacity, and high capital expenditures for cyclotron infrastructure. Supply chain volatility and the need for specialized handling also raise operational complexities, potentially slowing market adoption.

5. Which regions are leading the Lutetium-176 market?

North America remains the dominant region, accounting for roughly 45 % of global revenue, driven by extensive clinical trial networks and robust funding. Europe follows with strong academic collaborations, while Asia‑Pacific is emerging rapidly due to expanding healthcare infrastructure and government‑backed isotope programs.

6. Who are the top companies operating in this space?

The leading Lutetium-176 producers include ITM Isotope Technologies, ACME Isotopes, and Nordion Inc., complemented by specialized service firms such as GE Healthcare and Siemens Healthineers. These companies compete on production yield, purity standards, and integrated radiopharmacy solutions.

7. What future opportunities exist for market participants?

Future opportunities arise from personalized medicine initiatives, expanding theranostic combos that pair Lutetium-176 with novel targeting ligands, and cross‑border collaborations to scale production. Emerging applications in non‑oncologic diseases and AI‑driven dose optimization also promise new revenue streams.

8. How is technology influencing the Lutetium-176 market?

Advanced accelerator technologies and automated separation systems are enhancing Lutetium-176 isotope purity and reducing manufacturing lead times. Digital imaging integration and AI‑based treatment planning improve clinical outcomes, thereby boosting demand for high‑quality isotopic products across research and therapeutic settings.

9. What is the regulatory landscape for Lutetium-176?

The regulatory landscape for Lutetium-176 is governed by FDA’s IND/NDAs for radiopharmaceuticals in the U.S., EMA guidelines in Europe, and IAEA safety standards globally. Compliance requires rigorous quality control, traceability, and periodic audits, influencing time‑to‑market and cost structures.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Lutetium-176 Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	850.00 million
Revenue forecast in 2033	2.17 billion
Growth rate	CAGR of 12.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Rosatom; Cambridge Isotope Laboratories; Neonest AB
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options